[HTML][HTML] The role of SOX family members in solid tumours and metastasis

D Grimm, J Bauer, P Wise, M Krüger… - Seminars in cancer …, 2020 - Elsevier
Cancer is a heavy burden for humans across the world with high morbidity and mortality.
Transcription factors including sex determining region Y (SRY)-related high-mobility group …

Current opinion on molecular characterization for GBM classification in guiding clinical diagnosis, prognosis, and therapy

P Zhang, Q Xia, L Liu, S Li, L Dong - Frontiers in molecular …, 2020 - frontiersin.org
Glioblastoma (GBM) is highly invasive and the deadliest brain tumor in adults. It is
characterized by inter-tumor and intra-tumor heterogeneity, short patient survival, and lack of …

[HTML][HTML] Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients …

N Zhang, H Zhang, W Wu, R Zhou, S Li, Z Wang… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: Accumulating evidence demonstrated that long noncoding RNAs (lncRNAs)
involved in the regulation of the immune system and displayed a cell-type-specific pattern in …

Mutational landscape and significance across 12 major cancer types

C Kandoth, MD McLellan, F Vandin, K Ye, B Niu, C Lu… - Nature, 2013 - nature.com
Abstract The Cancer Genome Atlas (TCGA) has used the latest sequencing and analysis
methods to identify somatic variants across thousands of tumours. Here we present data and …

m6A modification in RNA: biogenesis, functions and roles in gliomas

Y Zhang, X Geng, Q Li, J Xu, Y Tan, M Xiao… - Journal of Experimental …, 2020 - Springer
The chemical modification of RNA is a newly discovered epigenetic regulation mechanism
in cells and plays a crucial role in a variety of biological processes. N6-methyladenine (m6A) …

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

S Turcan, D Rohle, A Goenka, LA Walsh, F Fang… - Nature, 2012 - nature.com
Both genome-wide genetic and epigenetic alterations are fundamentally important for the
development of cancers, but the interdependence of these aberrations is poorly understood …

[HTML][HTML] The molecular feature of macrophages in tumor immune microenvironment of glioma patients

H Zhang, YB Luo, W Wu, L Zhang, Z Wang… - Computational and …, 2021 - Elsevier
Background Gliomas are one of the most common types of primary tumors in central nervous
system. Previous studies have found that macrophages actively participate in tumor growth …

Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone

JM Lemée, A Clavreul, P Menei - Neuro-oncology, 2015 - academic.oup.com
Glioblastoma (GB) is the most frequent and aggressive primary tumor of the central nervous
system. Prognosis remains poor despite ongoing progress. In cases where the gadolinium …

Recent advances in the molecular understanding of glioblastoma

FE Bleeker, RJ Molenaar, S Leenstra - Journal of neuro-oncology, 2012 - Springer
Glioblastoma is the most common and most aggressive primary brain tumor. Despite
maximum treatment, patients only have a median survival time of 15 months, because of the …

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome …

P Bady, D Sciuscio, AC Diserens, J Bloch… - Acta …, 2012 - Springer
The methylation status of the O 6-methylguanine-DNA methyltransferase (MGMT) gene is an
important predictive biomarker for benefit from alkylating agent therapy in glioblastoma …